SBIO Coin Overview: Vector Space Biosciences’ Digital Equity Initiative
SBIO is a digital asset issued by the U.S. company Vector Space Biosciences, Inc., with its core purpose being to represent equity in the company. The project is actively pursuing the U.S. Securities and Exchange Commission (SEC) registration process for securities, aiming to provide holders with proof of ownership in the company and related benefits.SBIO is the company’s second token following VXV, reflecting its efforts to explore equity tokenization in the digital asset space.
Project Background and Technical Vision
Vector Space Biosciences, Inc. has a diversified R&D structure consisting primarily of three core laboratories:
- Bioscience Laboratory: Collaborating with the Scientific Advisory Board, this laboratory focuses on biomedical research.
- Hardware and CubeSat Laboratory: Responsible for designing and launching biological CubeSats for space-based biological experiments.
- Artificial Intelligence Laboratory: Covers cutting-edge technologies such as biological language modeling, generative AI, protein sequence matching, vector databases, and advanced visualization.
The project’s ambitious goal is to develop countermeasures against diseases caused by the stresses of human spaceflight and to expand these into novel precision medicine solutions applicable to all of humanity. By integrating biotechnology, aerospace engineering, and artificial intelligence, the company aims to achieve breakthroughs in the life sciences.
Token Economics and Market Performance
As an ERC-20 token, SBIO has a total supply and maximum supply of 100,000,000 SBIO. However, there are significant discrepancies in its circulating supply data: some reports indicate 10,000,000 SBIO (10% of the total supply),while platforms such as CoinMarketCap and Coinbase show 0 SBIO. This has led to substantial discrepancies in market capitalization data; for example, as of August 23, 2026, some sources reported a market capitalization of approximately $329,000, while others showed 0.
In terms of price, SBIO’s all-time high was approximately $0.87078 (reached on October 7, 2023).However, as of August 23, 2026, its price had fallen to approximately $0.0033, and discrepancies still exist among different data sources. More notably, SBIO’s 24-hour trading volume is extremely low, showing as zero or only a few hundred dollars in some data sources, indicating that its market liquidity is very limited.
Future Prospects and Challenges
Vector Space Biosciences plans to expand SBIO’s visibility and accessibility by listing on more exchanges and seeking inclusion on mainstream data platforms such as CoinGecko. The project team states that holding SBIO tokens will demonstrate ownership in the company and grant access to various benefits.If the SEC’s securities registration process is successfully completed, it is expected to bring SBIO greater compliance and institutional recognition.
However, the challenges facing SBIO cannot be overlooked. The current extremely low trading volume and inconsistent market capitalization data reflect low market interest and a severe lack of liquidity.Furthermore, as a digital asset intended to represent equity in the company, its value will be closely tied to Vector Space Biosciences’ actual business progress, research achievements, and the final outcome of its SEC registration. When considering such assets, investors must fully understand their unique nature as equity tokens, the potential regulatory risks, and the trading risks arising from insufficient market liquidity.
How to Acquire SBIO Tokens
Given that SBIO’s current trading volume on the market is extremely low—and even shows as zero on some platforms—the trading market for this token has virtually dried up, with a lack of effective transactions. Investors must fully understand the liquidity risks involved before attempting to acquire it.
